The IRR was 0.62 (95% CI: 0.400.95), and adjusted analyses indicated that people receiving semaglutide were significantly less likely to experience a stroke event than those receiving a DPP4i (HR: 0.63 [0.410.95]
Ready to start your weight loss journey with safe, legal online GLP-1 prescriptions
Many patients have already made the switch and are experiencing the benefits of starting treatment without delay
Universal design works seamlessly with most reusable GLP-1 pen injectors on the market, including those used for semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound)
Common side effects may include: In rare cases, serious side effects can occur
Caution is advised in patients with a history of pancreatitis, severe gastrointestinal disease, or diabetic retinopathy